Home > Boards > US Listed > Biotechs > Durect (DRRX)

The 4 million is from the offering a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Youlie Member Profile
 
Followed By 26
Posts 2,162
Boards Moderated 0
Alias Born 03/15/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/17/2020 2:35:32 PM
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR® PR Newswire (US) - 1/17/2020 6:45:00 AM
DURECT Corporation Trading Halted Today; FDA Advisory Committee to Discuss POSIMIR® (bupivacaine extended-release solution) ... PR Newswire (US) - 1/16/2020 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/6/2020 8:17:22 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/2/2020 1:31:19 PM
DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis PR Newswire (US) - 1/2/2020 9:00:00 AM
DURECT to Present at the Stifel 2019 Health Care Conference PR Newswire (US) - 11/15/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 5:08:19 PM
DURECT Corporation Announces Positive Results from the Phase 2a Clinical Trial of DUR-928 in Alcoholic Hepatitis Patients in ... PR Newswire (US) - 11/12/2019 8:45:00 AM
DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results PR Newswire (US) - 11/6/2019 5:47:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 3:37:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2019 4:21:37 PM
DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs PR Newswire (US) - 11/4/2019 4:05:00 PM
DURECT Corporation to Announce Third Quarter 2019 Financial Results and Provide Business Update on November 4 PR Newswire (US) - 10/30/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2019 1:00:03 PM
DURECT Announces DUR-928 Phase 2a Alcoholic Hepatitis Study Results Selected for Late-Breaking Oral Presentation at The Liver... PR Newswire (US) - 10/21/2019 10:12:00 AM
DURECT to Present at Two Upcoming NASH Investor Conferences PR Newswire (US) - 10/17/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/7/2019 3:30:55 PM
DURECT Announces Completion of Enrollment in its Phase 2a Clinical Trial of DUR-928 in Psoriasis and 50% Enrollment in its Ph... PR Newswire (US) - 10/7/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2019 3:31:06 PM
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR® for the Treatment of Post-Surgical Pain PR Newswire (US) - 10/2/2019 8:00:00 AM
DURECT to Present at the 2019 Cantor Fitzgerald Global Health Care Conference PR Newswire (US) - 9/26/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 10:48:26 AM
DURECT Announces Positive Data from its Phase 2a Clinical Trial of DUR-928 in Alcoholic Hepatitis PR Newswire (US) - 9/17/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 1:37:50 PM
Youlie   Wednesday, 10/09/19 02:42:13 PM
Re: hmuney post# 867
Post # of 967 
The 4 million is from the offering a few months back.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist